H5N1 avian influenza in children
Ahmet Faik Oner1, Nazim Dogan, Viktor Gasimov
1Yuzuncu Yil University, Van, Turkey.
Insights
Avian influenza (H5N1) in children has a high fatality rate, but early treatment with oseltamivir and symptoms like rhinorrhea improve survival. Prompt medical care is crucial for better outcomes in pediatric H5N1 cases.
Area of Science:
- Virology
- Epidemiology
- Pediatrics
Background:
- Avian influenza (H5N1) remains a significant human health threat with pandemic potential.
- Understanding H5N1 clinical presentation and prognosis in children is vital for effective management.
- Pediatric H5N1 cases require specific diagnostic and treatment strategies.
Purpose of the Study:
- To analyze the clinical presentation and prognostic factors for survival in pediatric H5N1 infection.
- To identify key indicators influencing outcomes in children diagnosed with H5N1.
- To evaluate the impact of treatment timing and specific symptoms on pediatric H5N1 mortality.
Main Methods:
- A global patient registry was utilized for systematic data collection on confirmed H5N1 pediatric cases.
- Clinical, exposure, treatment, and outcomes data were analyzed.
- Bivariate and multivariate statistical analyses were employed to determine prognostic factors.
Main Results:
- Data from 193 children across 13 countries revealed a 48.7% case fatality rate (CFR) for H5N1.
- Children aged ≤5 years had the lowest CFR and received faster treatment.
- Rhinorrhea was associated with a 76% reduced likelihood of death; delayed oseltamivir treatment increased mortality risk by 75% per day.
Conclusions:
- Rhinorrhea indicates a better prognosis for pediatric H5N1 patients, with most surviving.
- Early initiation of oseltamivir treatment significantly improves survival chances in children.
- Prompt medical intervention and symptom recognition are critical for managing H5N1 in pediatric populations.
Background:
Avian influenza continues to pose a threat to humans and maintains the potential for greater transmissibility. Understanding the clinical presentation and prognosis in children will help guide effective diagnosis and treatment.
Methods:
A global patient registry was created to enable systematic collection of clinical, exposure, treatment, and outcomes data on confirmed cases of H5N1. Bivariate and multivariate statistical tools were used to describe clinical presentation and evaluate factors prognostic of survival.
Results:
Data were available from 13 countries on 193 children <18 years who were confirmed as having been infected with H5N1; 35.2% of cases were from Egypt. The case fatality rate (CFR) for children was 48.7%, with Egypt having a very low pediatric CFR. Overall, children aged ≤5 years had the lowest CFR and were brought to hospitals more quickly and treated sooner than older children. Children who presented for medical care with a complaint of rhinorrhea had a 76% reduction in the likelihood of death compared with those who presented without rhinorrhea, even after statistical adjustment for age, having been infected in Egypt, and oseltamivir treatment (P = .02). Delayed initiation of treatment with oseltamivir increases the likelihood of death, with an overall 75% increase in the adjusted odds ratio for death for each day of delay.
Conclusions:
The presence of rhinorrhea appears to indicate a better prognosis for children with H5N1, with most patients surviving regardless of age, country, or treatment. For individuals treated with oseltamivir, early initiation of treatment substantially enhances the chance of survival.
More Related Videos
08:10Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses
Published on: January 15, 2020
08:46Rapid Diagnosis of Avian Influenza Virus in Wild Birds: Use of a Portable rRT-PCR and Freeze-dried Reagents in the Field
Published on: August 2, 2011
Related Concept Videos
Influenza
Viral Recombination
Arboviral Encephalitis
Viral Mutations
Hepatitis
Viral Meningitis
